CytRx Announces Positive Phase 2 Results For Tamibarotene in the Treatment of Relapsed Acute Promyelocytic Leukemia - Yahoo! Finance
Just an idea...
I'd seriously consider a buy at this point...
sorry for this short message, but don't have more time to write more..
I personally own this stock at 1,10US$/share
No comments:
Post a Comment